{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:22:47Z","timestamp":1790076167250,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jaut.2019.102312","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:56:24Z","timestamp":1565312184000},"page":"102312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Driving towards Precision Medicine for angioedema without wheals"],"prefix":"10.1016","volume":"104","author":[{"given":"Anastasios E.","family":"Germenis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.102312_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"HAWK under the patronage of EAACI, Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12016-016-8541-z","article-title":"Angioedema phenotypes: disease expression and classification","volume":"51","author":"Wu","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.iac.2013.07.001","article-title":"Diagnosing angioedema","volume":"33","author":"Cicardi","year":"2013","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.jaut.2019.102312_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102312_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mai.2000.108106","article-title":"Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema","volume":"106","author":"Binkley","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","article-title":"Mutation of angiopoietin-1 gene associates with a new type of hereditary angioedema","volume":"141","author":"Bafunno","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/all.13270","article-title":"Hereditary angioedema with a mutation in the plasminogen gene","volume":"73","author":"Bork","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/all.13869","article-title":"Hereditary angioedema cosegregating with a novel kininogen1 gene mutation changing the N-terminal cleavage site of bradykinin","author":"Bork","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12016-016-8544-9","article-title":"A decade of change: recent developments in pharmacotherapy of hereditary angioedema (HAE)","volume":"51","author":"Bork","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/14728222.2019.1608949","article-title":"Hereditary angioedema: examining the landscape of therapies and preclinical therapeutic targets","volume":"23","author":"Farkas","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jaut.2019.102312_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/14712598.2019.1595581","article-title":"Current and emerging biologics for the treatment of hereditary angioedema","volume":"19","author":"Perego","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jaut.2019.102312_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/323722a0","article-title":"An IgG autoantibody which inactivates C1-inhibitor","volume":"323","author":"Jackson","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102312_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.autrev.2008.05.003","article-title":"Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation","volume":"8","author":"Cugno","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2019.102312_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.autrev.2015.03.006","article-title":"The autoimmune side of hereditary angioedema: insights on the pathogenesis","volume":"14","author":"Triggianese","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2019.102312_bib15","first-page":"e104","article-title":"Acquired angioedema: a new target for rituximab?","volume":"89","author":"Ziakas","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.jaut.2019.102312_bib16","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2005.09.018","article-title":"Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency","volume":"119","author":"Levi","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2019.102312_bib17","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.molimm.2006.04.020","article-title":"C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate na\u00efve patients","volume":"44","author":"Varga","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3389\/fimmu.2018.01320","article-title":"Natural autoantibodies: an undersugn hero of the immune system and autoimmune disorders - a point of view","volume":"9","author":"Avrameas","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM198502283120902","article-title":"Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins","volume":"312","author":"Geha","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102312_bib20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2340\/00015555-2014","article-title":"Burden of illness in hereditary angioedema: a conceptual model","volume":"95","author":"Bygum","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jaut.2019.102312_bib21","first-page":"1002","article-title":"Hereditary kinin-mediated angioedema: current challenges","volume":"1","author":"Ghannam","year":"2016","journal-title":"Aust. Intern. Med."},{"key":"10.1016\/j.jaut.2019.102312_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12016-016-8543-x","article-title":"Genetics of hereditary angioedema revisited","volume":"51","author":"Germenis","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0091-6749(99)70030-8","article-title":"Local bradykinin generation in hereditary angioedema","volume":"104","author":"Nussberger","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102312_bib25","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jaci.2009.08.007","article-title":"Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency","volume":"124","author":"Bossi","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102312_bib27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41598-017-16667-w","article-title":"Intermittent C1-inhibitor deficiency associated with recessive inheritance: functional and structural insight","volume":"8","author":"Caccia","year":"2018","journal-title":"Sci. Rep."},{"issue":"45","key":"10.1016\/j.jaut.2019.102312_bib28","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1016\/j.molimm.2008.05.007","article-title":"Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates","volume":"45","author":"Pappalardo","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaci.2014.08.007","article-title":"Hereditary angioedema: molecular and clinical differences among European populations","volume":"135","author":"Speletas","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gene.2018.05.029","article-title":"Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency","volume":"667","author":"Loules","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.jaut.2019.102312_bib31","article-title":"A deep intronic SERPING1 variant associated with hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE)","author":"Vatsiou","year":"2019","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","article-title":"Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor","volume":"343","author":"Dewald","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2019.102312_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2011.07.002","article-title":"A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor","volume":"141","author":"Bork","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2013.08.001","article-title":"Novel duplication in the F12 gene in a patient with recurrent angioedema","volume":"149","author":"Kiss","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib35","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/all.12648","article-title":"Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations","volume":"70","author":"Bork","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib36","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI77139","article-title":"Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III","volume":"125","author":"Bj\u00f6rkqvist","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2019.102312_bib37","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jth.13383","article-title":"Factor XII: form determines function","volume":"14","author":"de Maat","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jaut.2019.102312_bib38","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaci.2016.02.021","article-title":"Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations","volume":"138","author":"de Maat","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib39","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2018-06-860270","article-title":"A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain","volume":"133","author":"Ivanov","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2019.102312_bib40","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/all.12648","article-title":"Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations","volume":"70","author":"Bork","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.iac.2017.04.004","article-title":"HAE with normal C1INH: update on evaluation and treatment","volume":"37","author":"Magerl","year":"2017","journal-title":"Immunol. Allergy Clin. N. Am."},{"issue":"Suppl 2","key":"10.1016\/j.jaut.2019.102312_bib42","first-page":"29","article-title":"Genotyping unknown hereditary angioedema (U-HAE) and idiopathic non-histaminergic acquired angioedema (Inh-AAE): preliminary evidence of pathogenic variants","volume":"13","author":"Zamanakou","year":"2017","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbrc.2017.12.060","article-title":"A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor","volume":"498","author":"Dewald","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2019.102312_bib44","article-title":"Variant pathogenicity curation in primary angioedema with normal C1 inhibitor (nl-C1-INH-HAE)","author":"Loules","year":"2019","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib45","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/all.13324","article-title":"On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema","volume":"73","author":"Germenis","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib46","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/all.13543","article-title":"Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families","volume":"73","author":"Belb\u00e9zier","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13601-019-0247-x","article-title":"Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema","volume":"9","author":"Recke","year":"2019","journal-title":"Clin. Transl. Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(83)90052-0","article-title":"Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of \u201cspontaneous\u201d formation of bradykinin","volume":"72","author":"Fields","year":"1983","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib49","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102312_bib50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/cs0870567","article-title":"Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects","volume":"87","author":"Pellacani","year":"1994","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jaut.2019.102312_bib51","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2019.102312_bib52","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/cea.12293","article-title":"High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency","volume":"44","author":"Suffritti","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib53","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jaci.2017.07.012","article-title":"Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema","volume":"140","author":"Hofman","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1605767","article-title":"Inhibiting plasma kallikrein for hereditary angioedema prophylaxis","volume":"376","author":"Banerji","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102312_bib55","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/cea.13219","article-title":"Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema","volume":"48","author":"Lara-Marquez","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib56","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1684\/ejd.2015.2547","article-title":"Towards a specific marker for acute bradykinin-mediated angioedema attacks: a literature review","volume":"25","author":"Deroux","year":"2015","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jaut.2019.102312_bib57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12016-016-8539-6","article-title":"\u201cNuts and bolts\u201d of laboratory evaluation of angioedema","volume":"51","author":"Farkas","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.iac.2017.04.008","article-title":"Laboratory approaches for assessing contact system activation","volume":"37","author":"Christiansen","year":"2017","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.jaut.2019.102312_bib59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fmed.2017.00206","article-title":"The search for biomarkers in hereditary angioedema","volume":"4","author":"Kaplan","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2019.102312_bib60","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/all.12714","article-title":"F12-46C\/T polymorphism as modifier of the clinical phenotype of hereditary angioedema","volume":"70","author":"Speletas","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib61","first-page":"200","article-title":"Genetic determinants of the C1-INH deficiency angioedema (C1-INH-HAE) age of onset","volume":"174","author":"Gianni","year":"2017","journal-title":"Int. J. Allergy Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2222.2009.03323.x","article-title":"Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors","volume":"40","author":"Hoover","year":"2010","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jaut.2019.102312_bib63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FPC.0b013e328363c137","article-title":"Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema","volume":"23","author":"Pare","year":"2013","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.jaut.2019.102312_bib64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0031-6997(25)00449-1","article-title":"Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology","volume":"45","author":"Roques","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jaut.2019.102312_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5603\/CJ.a2016.0063","article-title":"Neprilysin inhibition: a brief review of past pharmacological strategies for heart failure treatment and future directions","volume":"23","author":"Howell","year":"2016","journal-title":"Cardiol. J."},{"key":"10.1016\/j.jaut.2019.102312_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000355938","article-title":"Biomarkers in rare diseases","volume":"16","author":"Ferlini","year":"2013","journal-title":"Public Health Genomics"},{"key":"10.1016\/j.jaut.2019.102312_bib67","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11136-009-9509-8","article-title":"Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema","volume":"18","author":"Vernon","year":"2009","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jaut.2019.102312_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11597490-000000000-00000","article-title":"Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study","volume":"5","author":"McMillan","year":"2012","journal-title":"Patient"},{"key":"10.1016\/j.jaut.2019.102312_bib69","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1185\/03007995.2014.954032","article-title":"The quantified patient: a patient participatory culture","volume":"30","author":"Appelboom","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"issue":"60","key":"10.1016\/j.jaut.2019.102312_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jbi.2016.02.002","article-title":"A user-centered model for designing consumer mobile health (mHealth) applications (apps)","volume":"60","author":"Schnall","year":"2016","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.jaut.2019.102312_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrclinonc.2010.227","article-title":"Predictive, personalized, preventive, participatory (P4) cancer medicine","volume":"8","author":"Hood","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jaut.2019.102312_bib72","first-page":"342","article-title":"Personalized medicine: from genotypes, molecular phenotypes and the quantified self, towards improved medicine","author":"Dudley","year":"2015","journal-title":"Pac. Symp. Biocomput."},{"key":"10.1016\/j.jaut.2019.102312_bib73","series-title":"The International Registry for Angioedema without Wheals","author":"Perego","year":"2017"},{"key":"10.1016\/j.jaut.2019.102312_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ajmg.c.31533","article-title":"Alternative designs for clinical trials in rare diseases","volume":"172","author":"Abrahamyan","year":"2016","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"10.1016\/j.jaut.2019.102312_bib75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13643-017-0479-6","article-title":"N of 1 trials and the optimal individualisation of drug treatments: a systematic review protocol","volume":"6","author":"Demeyin","year":"2017","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jaut.2019.102312_bib77","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1613627","article-title":"COMPACT Investigators, Prevention of hereditary angioedema attacks with a subcutaneous C1 Inhibitor","volume":"376","author":"Longhurst","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102312_bib78","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000441060","article-title":"Icatibant for multiple hereditary angioedema attacks across the controlled and open-label extension phases of FAST-3","volume":"168","author":"Lumry","year":"2015","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jaut.2019.102312_bib79","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.jaip.2017.04.010","article-title":"Treatment effect and safety of icatibant in pediatric patients with hereditary angioedema","volume":"5","author":"Farkas","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.jaut.2019.102312_bib80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2217\/pme.11.7","article-title":"The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?","volume":"8","author":"Lillie","year":"2011","journal-title":"Per. Med."},{"key":"10.1016\/j.jaut.2019.102312_bib81","doi-asserted-by":"crossref","DOI":"10.1111\/cea.13470","article-title":"The functional promoter F12-46C\/T variant predicts the asymptomatic phenotype of C1-INH-HAE","author":"Rijavec","year":"2019","journal-title":"Clin. Exp. Allergy"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119304718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119304718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:22:52Z","timestamp":1760257372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119304718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":80,"alternative-id":["S0896841119304718"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102312","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Driving towards Precision Medicine for angioedema without wheals","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102312"}}